Crossmark

Development and internal validation of a machine learning-based model to predict 1-year all-cause mortality in patients with gastrointestinal bleeding with type 2 diabetes

Crossref DOI link: https://doi.org/10.1186/s12911-026-03447-8

Published Online: 2026-03-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xiangru

Wang, Yuchen

Liu, Haiwang
License Information

Text and Data Mining valid from 2026-03-24

Version of Record valid from 2026-05-04
More Information

Article History

Received: 17 July 2025

Accepted: 16 March 2026

First Online: 24 March 2026

Declarations

:

: This study was conducted in accordance with the principles of the Declaration of Helsinki. The Beth Israel Deaconess Medical Center (BIDMC) managed study approvals with human participants, anonymizing patient data for privacy. Ethical Committee of the Beth Israel Deaconess Medical Center exempted informed consent requirements.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below